Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?

High Blood Pressure and Cardiovascular Prevention

Volumn 23, Issue 2, 2016, Pages 97-104

  Coca, Antonio ^a   Monteagudo, Eila ^a   Doménech, Mónica ^a   Camafort, Miguel ^a   Sierra, Cristina ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cognitive impairment; Dementia; Hypertension; Silent brain damage

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COGNITION; DEMENTIA; DEPERSONALIZATION; DISORIENTATION; HUMAN; HYPERTENSION; INCIDENCE; LACUNAR STROKE; MENTAL DETERIORATION; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOPHYSIOLOGY; PERIVASCULAR SPACE; PRIORITY JOURNAL; RISK ASSESSMENT; WHITE MATTER; AGE; AGING; BLOOD PRESSURE; DRUG EFFECT; PSYCHOLOGY; RISK FACTOR; TREATMENT OUTCOME;

AGE FACTORS; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COGNITION; DEMENTIA; HUMANS; HYPERTENSION; INCIDENCE; MAGNETIC RESONANCE IMAGING; RISK FACTORS; TREATMENT OUTCOME;

EID: 84977079552     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.1007/s40292-016-0144-5     Document Type: Article

References (46)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.
2. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35:2950–9.
3. Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health. 2006;27:465–90.
4. Banegas JR, Graciani A, de la Cruz-Troca JJ, León-Muñoz LM, Guallar-Castillón P, Coca A, et al. Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study. Hypertension. 2012;60:898–905.
5. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.
6. Begum A, Dewey M, Hassiotis A, Prince M, Wessely S, Stewart R, et al. Subjective cognitive complaints across the adult life span: a 14-year analysis of trends and associations using the 1993, 2000 and 2007 English Psychiatric Morbidity Surveys. Psychol Med. 2014;44:1977–87.
7. Stewart R, Godin O, Crivello F, Maillard P, Mazoyer B, Tzourio C, et al. Longitudinal neuroimaging correlates of subjective memory impairment: 4-year prospective community study. Br J Psychiatry. 2011;198:199–205.
8. Qiu C, Winblad B, Fratiglioni L. The age dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487–99.
9. Gorelick PB, Scuteri A, Black SE, DeCarli Ch, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia. A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.
10. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Aging Res Rev. 2002;1:61–77.
11. Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer’s disease-lessons from pathology. BMC Med. 2014;12:206.
12. Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, et al. Vascular contributions to cognitive impairment and dementia including Alzheimer’s disease. Alzheimers Dement. 2015;11:710–7.
13. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia. How to move forward? Neurology. 2009;72:368–74.
14. Eckerström M, Skoogh J, Rolstad S, Göthlin M, Steineck G, Johansson B, et al. Sahlgrenska Academy Self-reported Cognitive Impairment Questionnaire (SASCI-Q)-a research tool discriminating between subjectively cognitively impaired patients and healthy controls. Int Psychogeriatr. 2013;25:420–30.
15. Montejo P, Montenegro M, Fernandez MA, Maestu F. Subjective memory complaints in the elderly: prevalence and influence of temporal orientation, depression and quality of life in a population-based study in the city of Madrid. Aging Ment Health. 2011;15:85–96.
16. Zlatar ZZ, Moore RC, Palmer BW, Thompson WK, Jeste DV. Cognitive complaints correlate with depression rather than concurrent objective cognitive impairment in the successful aging evaluation baseline sample. J Geriatr Psychiatry Neurol. 2014;27:181–7.
17. Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, et al. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. Int Psychogeriatr. 2013;25:1307–15.
18. Scuteri A, Tesauro M, Guglini L, Lauro D, Fini M, Di Daniele N, et al. Aortic stiffness and hypotension episodes are associated with impaired cognitive function in older subjects with subjective complaints of memory loss. Int J Cardiol. 2013;169:371–7.
19. Triantafyllidi H, Arvaniti C, Lekakis J, Ikonomidis I, Siafakas N, Tzortzis S, et al. Cognitive impairment is related to increased arterial stiffness and microvascular damage in patients with never-treated essential hypertension. Am J Hypertens. 2009;22:525–30.
20. Singer J, Trollor JN, Baune BT, Sachdev PS, Smith E. Arterial stiffness, the brain and cognition: a systematic review. Ageing Res Rev. 2014;15:16–27.
21. Sierra C, Doménech M, Camafort M, Coca A. Hypertension and mild cognitive impairment. Curr Hypertens Rep. 2012;14:548–55.
22. Kearney-Schwartz A, Rossignol P, Bracard S, Felblinger J, Fay R, Boivin JM, et al. Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints. Stroke. 2009;40:1229–36.
23. Jia Z, Mohammed W, Qiu Y, Hong X, Shi H. Hypertension increases the risk of cerebral microbleed in the territory of posterior cerebral artery: a study of the association of microbleeds categorized on a basis of vascular territories and cardiovascular risk factors. J Stroke Cerebrovasc Dis. 2014;23:e5–11.
24. Van Norden AGW, van Uden IWM, de Laat KF, Gons RAR, Kessels RPC, van Dijk EJ, et al. Cerebral microbleeds are related to subjective cognitive failures: the RUN DMC study. Neurobiol Aging. 2013;34:2225–30.
25. Uiterwijk R, Huijts M, Staals J, Duits A, Gronenschild E, Kroon AA, et al. Subjective cognitive failures in patients with hypertension are related to cognitive performance and cerebral microbleeds. Hypertension. 2014;64:653–7.
26. Sierra C, de la Sierra A, Salamero M, Sobrino J, Gómez-Angelats E, Coca A. Silent cerebral white matter lesions and cognitive function in middle-aged essential hypertensive patients. Am J Hypertens. 2004;17:529–34.
27. Sierra C, Coca A. Brain damage. In: G. Mancia, G. Grassi, J. Redon, editors. Manual of hypertension of the European society of hypertension, 2nd ed. 2014. p. 177–189.
28. Carey CL, Kramer JH, Josephson SA, Mungas D, Reed BR, Schuff N, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke. 2008;39:397–402.
29. Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten ECW, van der Flier WM, et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology. 2011;76:1872–8.
30. Baune BT, Roesler A, Knecht S, Berger K. Single and combined effects of cerebral white matter lesions and lacunar infarctions on cognitive function in an elderly population. J Gerontol Biol Sci Med Sci. 2009;64:118–24.
31. Potter GM, Doubal FN, Jackson CA, Chappell FM, Sudlow CL, Dennis MS, et al. Enlarged perivascular spaces and cerebral small vessel disease. Int J Stroke. 2015;10(3):376–81.
32. Maclullich AMJ, Wardlaw JM, Ferguson KJ, Starr JM, Seckl JR, Deary IJ, et al. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry. 2004;75:1519–23.
33. Huijts M, Duits A, van Oostenbrugge RJ, Kroon AA, de Leeuw PW, Staals J, et al. Accumulation of MRI markers of cerebral small vessel disease is associated with decreased cognitive function. A study in first-ever lacunar stroke and hypertensive patients. Front Aging Neurosci. 2013;5:72.
34. Levi Marpillat N, Macquin-Mavier I, Tropeano AI, Bachoud-Levi AC, Maison P. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens. 2013;31:1073–82.
35. Yasar S, Xia J, Yao W, Furberg C, Xue OL, Mercado CI, et al. For the Ginkgo Evaluation of Memory Study. Antihypertensive drugs decrease risk of Alzheimer disease. Neurology. 2013;81:896–903.
36. Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation. 2011;123:266–73.
37. Coca A. Hypertension and vascular dementia in the elderly: the potential role of anti-hypertensive agents. Curr Med Res Opin. 2013;29:1045–54.
38. Chiu WC, Ho WC, Lin MH, Lee HH, Ye YC, Wang JD, For the Data Analysis in Taiwan (hDATa) Research Group, et al. Angiotension receptor blockers reduce the risk of dementia. J Hypertens. 2014;32:938–47.
39. Forette F, Seux M, Staessen J, Thijs L, Birkenhäger W, Babarskiene MR, et al. Prevention of dementia in a randomised double-blind placebo controlled systolic hypertension in Europe (SYST-EUR) trial. Lancet. 1998;352:1347–51.
40. Forette F, Seux M, Staessen J, Thijs L, Babarskiene M, Babeanu S, Systolic hypertension in Europe investigators, et al. The prevention of dementia with antihypertensive treatment. Arch Int Med. 2002;162:2046–52.
41. Tomassioni D, Lanari A, Silvestrelli G, Traini E, Amenta F. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical trials. Clin Exp Hypertens. 2008;30:744–66.
42. Trompet S, Westendorp R, Kamper A, Craen A. Use of calcium antagonists and cognitive decline in old age. The Leiden 85-plus study. Neurobiol Aging. 2008;29:306–8.
43. Paran E, Anson O, Lowenthal D. Cognitive functioning and antihypertensive treatment in the elderly: a 6-year follow-up study. Am J Ther. 2010;17:358–64.
44. Maxwell C, Hogan D, Ebly E. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian study of health and aging. CMAJ. 1999;161:501–6.
45. Peters R, Booth A, Peters J. A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly. J Hypertens. 2014;32:1945–58.
46. Peters R, Collerton J, Granic A, Davies K, Kirkwood T, Jagger C. Antihypertensive drug use and risk of cognitive decline in the very old: an observational study—the Newcastle 85+ Study. J Hypertens. 2015;33:2156–64.